Cargando…

Coxsackievirus B3 targets TFEB to disrupt lysosomal function

Coxsackievirus B3 (CVB3) is a prevalent etiological agent for viral myocarditis and neurological disorders, particularly in infants and young children. Virus-encoded proteinases have emerged as cytopathic factors that contribute to disease pathogenesis in part through targeting the cellular recyclin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamud, Yasir, Tang, Hui, Xue, Yuan Chao, Liu, Huitao, Ng, Chen Seng, Bahreyni, Amirhossein, Luo, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726691/
https://www.ncbi.nlm.nih.gov/pubmed/33691586
http://dx.doi.org/10.1080/15548627.2021.1896925
_version_ 1784626358022832128
author Mohamud, Yasir
Tang, Hui
Xue, Yuan Chao
Liu, Huitao
Ng, Chen Seng
Bahreyni, Amirhossein
Luo, Honglin
author_facet Mohamud, Yasir
Tang, Hui
Xue, Yuan Chao
Liu, Huitao
Ng, Chen Seng
Bahreyni, Amirhossein
Luo, Honglin
author_sort Mohamud, Yasir
collection PubMed
description Coxsackievirus B3 (CVB3) is a prevalent etiological agent for viral myocarditis and neurological disorders, particularly in infants and young children. Virus-encoded proteinases have emerged as cytopathic factors that contribute to disease pathogenesis in part through targeting the cellular recycling machinery of autophagy. Although it is appreciated that CVB3 can usurp cellular macroautophagy/autophagy for pro-viral functions, the precise mechanisms by which viral proteinases disrupt autophagy remain incompletely understood. Here we identified TFEB (transcription factor EB), a master regulator of autophagy and lysosome biogenesis, as a novel target of CVB3 proteinase 3 C. Time-course infections uncovered a significant loss of full-length TFEB and the emergence of a lower-molecular mass (~63 kDa) fragment. Cellular and in vitro cleavage assays revealed the involvement of viral proteinase 3 C in the proteolytic processing of TFEB, while site-directed mutagenesis identified the site of cleavage after glutamine 60. Assessment of TFEB transcriptional activity using a reporter construct discovered a loss of function of the cleavage fragment despite nuclear localization and retaining of the ability of DNA and protein binding. Furthermore, we showed that CVB3 infection was also able to trigger cleavage-independent nuclear translocation of TFEB that relied on the serine-threonine phosphatase PPP3/calcineurin. Finally, we demonstrated that both TFEB and TFEB [Δ60] serve roles in viral egress albeit through differing mechanisms. Collectively, this study reveals that CVB3 targets TFEB for proteolytic processing to disrupt host lysosomal function and enhance viral infection. Abbreviations:ACTB: actin beta; CLEAR: coordinated lysosomal enhancement and regulation; CVB3: coxsackievirus B3; DAPI: 4′,6-diamidino-2-phenylindole; GFP: green fluorescent protein; LAMP1: lysosomal associated membrane protein 1; LTR: LysoTracker Red; PPP3/calcineurin: protein phosphatase 3; PPP3CA: protein phosphatase 3 catalytic subunit A; p-TFEB: phospho-Ser211 TFEB; si-CON: scramble control siRNA; TFEB: transcription factor EB; TFEB [Δ60]: TFEB cleavage fragment that lacks the first 60 amino acids; VP1: viral capsid protein 1
format Online
Article
Text
id pubmed-8726691
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-87266912022-01-05 Coxsackievirus B3 targets TFEB to disrupt lysosomal function Mohamud, Yasir Tang, Hui Xue, Yuan Chao Liu, Huitao Ng, Chen Seng Bahreyni, Amirhossein Luo, Honglin Autophagy Research Paper Coxsackievirus B3 (CVB3) is a prevalent etiological agent for viral myocarditis and neurological disorders, particularly in infants and young children. Virus-encoded proteinases have emerged as cytopathic factors that contribute to disease pathogenesis in part through targeting the cellular recycling machinery of autophagy. Although it is appreciated that CVB3 can usurp cellular macroautophagy/autophagy for pro-viral functions, the precise mechanisms by which viral proteinases disrupt autophagy remain incompletely understood. Here we identified TFEB (transcription factor EB), a master regulator of autophagy and lysosome biogenesis, as a novel target of CVB3 proteinase 3 C. Time-course infections uncovered a significant loss of full-length TFEB and the emergence of a lower-molecular mass (~63 kDa) fragment. Cellular and in vitro cleavage assays revealed the involvement of viral proteinase 3 C in the proteolytic processing of TFEB, while site-directed mutagenesis identified the site of cleavage after glutamine 60. Assessment of TFEB transcriptional activity using a reporter construct discovered a loss of function of the cleavage fragment despite nuclear localization and retaining of the ability of DNA and protein binding. Furthermore, we showed that CVB3 infection was also able to trigger cleavage-independent nuclear translocation of TFEB that relied on the serine-threonine phosphatase PPP3/calcineurin. Finally, we demonstrated that both TFEB and TFEB [Δ60] serve roles in viral egress albeit through differing mechanisms. Collectively, this study reveals that CVB3 targets TFEB for proteolytic processing to disrupt host lysosomal function and enhance viral infection. Abbreviations:ACTB: actin beta; CLEAR: coordinated lysosomal enhancement and regulation; CVB3: coxsackievirus B3; DAPI: 4′,6-diamidino-2-phenylindole; GFP: green fluorescent protein; LAMP1: lysosomal associated membrane protein 1; LTR: LysoTracker Red; PPP3/calcineurin: protein phosphatase 3; PPP3CA: protein phosphatase 3 catalytic subunit A; p-TFEB: phospho-Ser211 TFEB; si-CON: scramble control siRNA; TFEB: transcription factor EB; TFEB [Δ60]: TFEB cleavage fragment that lacks the first 60 amino acids; VP1: viral capsid protein 1 Taylor & Francis 2021-03-10 /pmc/articles/PMC8726691/ /pubmed/33691586 http://dx.doi.org/10.1080/15548627.2021.1896925 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Paper
Mohamud, Yasir
Tang, Hui
Xue, Yuan Chao
Liu, Huitao
Ng, Chen Seng
Bahreyni, Amirhossein
Luo, Honglin
Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title_full Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title_fullStr Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title_full_unstemmed Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title_short Coxsackievirus B3 targets TFEB to disrupt lysosomal function
title_sort coxsackievirus b3 targets tfeb to disrupt lysosomal function
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726691/
https://www.ncbi.nlm.nih.gov/pubmed/33691586
http://dx.doi.org/10.1080/15548627.2021.1896925
work_keys_str_mv AT mohamudyasir coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT tanghui coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT xueyuanchao coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT liuhuitao coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT ngchenseng coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT bahreyniamirhossein coxsackievirusb3targetstfebtodisruptlysosomalfunction
AT luohonglin coxsackievirusb3targetstfebtodisruptlysosomalfunction